DuVax Vaccines and Reagents

DuVax Vaccines and Reagents was a Canadian vaccine biotechnology company spun out of the University of Victoria to commercialize a patented platform for creating temperature-sensitive live bacterial vaccines. Its core technology used essential genes from Arctic bacteria to engineer pathogenic bacteria that can replicate at cooler temperatures but are inactivated at warmer core body temperatures, with the goal of improving safety while preserving the immunogenicity of live vaccines. The company positioned the platform for both human and animal health applications and indicated potential applicability across multiple bacterial pathogens. Publicly available evidence suggests DuVax remained an early-stage private company focused on platform development rather than a broad disclosed clinical pipeline. More recent company-directory sources describe the company as no longer active or "deadpooled."